• Marcaine Spinal (Bupivacaine) 0.5% 4ml 5 vials

Expiration date: 10/2025

Structure and Composition:

Injection. 1 ml contains:

bupivacaine 5 mg

8 mg sodium monochloride

Excipients: sodium hydroxide and / or hydrochloric acid to correct pH Water for Injection

ampoules of 4 ml in a cardboard box of 5 pcs.

Dosage and administration:

Spinal administration of the preparation is carried out only after a clear definition of the subarachnoid space by lumbar features. You can not inject the drug until out will not stand out spinal needle clear cerebrospinal fluid (spontaneously or aspiration). The indicator of inefficient spinal anesthesia is 1-5%. One reason - a violation of local anesthetic in the distribution intrathecal space due to its accumulation in the caudal part of or in communication with the main hindered cerebrospinal space. In such cases, adequate blockade can be achieved by changing the position of the patient's body. If you want to conduct more blockade, it is performed on a different level, using a smaller amount of local anesthetic. Allowed to hold no more than one more attempt.

Clinical and side effects of spinal bupivacaine at a dose greater than 20 mg have not been studied.

In adults, on the background of spinal blockade hypotension usually develops.

The development of anesthesia is slower than with lidocaine, anesthesia duration from 60 to 120 minutes.

The recommended dose for the drug marcaine Spinal:

There are large individual differences in the nature of the distribution, the beginning and duration of drug action, so the recommended dose in the table should be regarded as indicative.

The level of anesthesiaArea puncturePosition the patient's body
DoseThe onset of action, minutesDuration, hours
mlng
L1
Indications: surgery of the lower limbs, perineum, urological surgery
L3/4/5Horisontal2-310-155-82-3
Th10
Indications: hip surgery, abdominal surgery
L2/3/4Horisontal
3-415-205-83-4


Marcaine
Spinal
(Bupivacaine)
0.5%
4ml
5
vials